Influsome-Vac (NasVax)
N/A
Report date: 2022/11/27 16:44:49
Base Information
Drug NameInflusome-Vac (NasVax)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTherapix Biosciences Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesTherapix Biosciences Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A